Brusatol enhances ferroptosis susceptibility in nasopharyngeal carcinoma by downregulating Nrf2 expression.

Nasopharyngeal carcinoma (NPC) is characterized by high metastatic potential and invasiveness, posing significant therapeutic challenges. Existing treatment methods remain limited, and new therapeutic strategies are urgently needed. Brusatol, a natur…

Preview only. Read the full abstract at the source